Geroscience

Therapies that inhibit aging biology, such as caloric restriction, metformin, senolytics, or rapalogs, may slow the development and progression of disease and functional decline in humans.

Corresponding Author: Stephen B. Kritchevsky, PhD, Department of Internal Medicine, Section on Gerontology and Geriatric Medicine, Wake Forest University of School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157 (skritche@wakehealth.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.